Staging of biliary atresia at diagnosis by molecular profiling of the liver

Genome Medicine

Volumn 2, Issue 5, 2010, Pages

  Moyer, Katie ^a   Kaimal, Vivek ^a   Pacheco, Cristina ^a,d   Mourya, Reena ^a   Xu, Huan ^a   Shivakumar, Pranavkumar ^a   Chakraborty, Ranajit ^b   Rao, Marepalli ^b   Magee, John C ^c   Bove, Kevin ^a   Aronow, Bruce J ^a   Jegga, Anil G ^a   Bezerra, Jorge A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT ATRESIA; BIOACCUMULATION; CELL POPULATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; GENE PROBE; GRAFT SURVIVAL; HEPATITIS; HUMAN; HUMAN TISSUE; INFANT; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTE; MALE; PRIORITY JOURNAL; SURVIVAL; TREATMENT RESPONSE;

EID: 78751681685     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm154     Document Type: Article

References (35)

1. Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996, 23:1682-1692. 10.1002/hep.510230652, 8675193.
2. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 2007, 27:233-242. 10.1055/s-2007-985068, 17682970.
3. Bezerra JA, Tiao G, Ryckman FC, Alonso M, Sabla GE, Shneider B, Sokol RJ, Aronow BJ. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002, 360:1653-1659. 10.1016/S0140-6736(02)11603-5, 12457789.
4. Mack CL, Falta MT, Sullivan AK, Karrer F, Sokol RJ, Freed B, Fontenot AP. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology 2007, 133:278-287. 10.1053/j.gastro.2007.04.032, 1949019, 17631149.
5. Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, Miller SD. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004, 56:79-87. 10.1203/01.PDR.0000130480.51066.FB, 1948976, 15128911.
6. Mack CL, Tucker RM, Lu BR, Sokol RJ, Fontenot AP, Ueno Y, Gill RG. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006, 44:1231-1239. 10.1002/hep.21366, 1948978, 17058262.
7. Shivakumar P, Sabla G, Mohanty S, McNeal M, Ward R, Stringer K, Caldwell C, Chougnet C, Bezerra JA. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007, 133:268-277. 10.1053/j.gastro.2007.04.031, 2013308, 17631148.
8. Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM, Ward RL, Bezerra JA. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004, 114:322-329. 484981, 15286798.
9. Petersen C, Kuske M, Bruns E, Biermanns D, Wussow PV, Mildenberger H. Progress in developing animal models for biliary atresia. Eur J Pediatr Surg 1998, 8:137-141. 10.1055/s-2008-1071140, 9676394.
10. Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, Fisher J, Ogra PL. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993, 33:394-399.
11. Davenport M, Caponcelli E, Livesey E, Hadzic N, Howard E. Surgical outcome in biliary atresia: Etiology affects the influence of age at surgery. Ann Surg 2008, 247:694-698. 10.1097/SLA.0b013e3181638627, 18362634.
12. Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, Splitz L. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 2004, 363:1354-1357. 10.1016/S0140-6736(04)16045-5, 15110492.
13. DeRusso PA, Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, Schwarz KB, Bezerra JA, Rosenthal P, Karpen S, Squires RG, Magee JC, Robuck PR, Sokol RJ. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology 2007, 46:1632-1638. 10.1002/hep.21923, 17929308.
14. Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, Butzner JD, Wrobel I, Mack D, Moroz S, Rashid M, Persad R, Levesque D, Brill H, Bruce G, Critch J. Biliary atresia: the Canadian experience. J Pediatr 2007, 151:659-665.
15. Serinet MO, Broue P, Jacquemin E, Lachaux A, Sarles J, Gottrand F, Gauthier F, Chardot C. Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. Hepatology 2006, 44:75-84. 10.1002/hep.21219, 16799986.
16. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, Shepherd R, Rosenthal P, Hoofnagle JH, Sokol RJ. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006, 148:467-474. 10.1016/j.jpeds.2005.12.054, 16647406.
17. Wu ET, Chen HL, Ni YH, Lee PI, Hsu HY, Lai HS, Chang MH. Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int 2001, 17:390-395. 10.1007/s003830000573, 11527173.
18. Azarow KS, Phillips MJ, Sandler AD, Hagerstrand I, Superina RA. Biliary atresia: should all patients undergo a portoenterostomy?. J Pediatr Surg 1997, 32:168-172. discussion 172-164, 10.1016/S0022-3468(97)90173-1, 9044116.
19. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr 2004, 144:123-125. 10.1016/j.jpeds.2003.09.042, 14722530.
20. Pape L, Olsson K, Petersen C, von Wasilewski R, Melter M. Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transpl 2009, 15:876-882. 10.1002/lt.21711, 19642116.
21. Whitington PF. Fortune telling in biliary atresia: what is in the tea leaves?. Liver Transpl 2009, 15:829-830. 10.1002/lt.21740, 19642119.
22. Carvalho E, Liu C, Shivakumar P, Sabla G, Aronow B, Bezerra JA. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005, 129:713-717.
23. Zhang D-Y, Sabla G, Shivakumar P, Tiao G, Sokol RJ, Mack C, Shneider BL, Aronow BJ, Bezerra JA. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 2004, 39:954-962. 10.1002/hep.20135, 15057899.
24. Oberthuer A, Warnat P, Kahlert Y, Westermann F, Spitz R, Brors B, Hero B, Elis R, Schwab M, Berthold F, Fischer M. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease. Cancer Lett 2007, 250:250-267. 10.1016/j.canlet.2006.10.016, 17126996.
25. Ruschhaupt M, Huber W, Poustka A, Mansmann U. A compendium to ensure computational reproducibility in high-dimensional classification tasks. Stat Appl Genet Mol Biol 2004, 3:Article37.
26. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002, 99:6567-6572. 10.1073/pnas.082099299, 124443, 12011421.
27. Genomatix. , http://www.genomatix.de
28. Everitt BS, Hothorn T. A Handbook of Statistical Analyis Using R 2005, London: CRC Press.
29. Feng J, Li M, Cai T, Tang H, Gu W. Rotavirus-induced murine biliary atresia is mediated by nuclear factor-kappaB. J Pediatr Surg 2005, 40:630-636. 10.1016/j.jpedsurg.2004.12.004, 15852269.
30. Gyorffy A, Baranyai Z, Cseh A, Munkacsy G, Jakab F, Tulassay Z, Gyorffy B. Promoter analysis suggests the implication of NFkappaB/C-Rel transcription factors in biliary atresia. Hepatogastroenterology 2008, 55:1189-1192.
31. Corsino P, Davis B, Law M, Chytil A, Forrester E, Norgaard P, Teoh N, Law B. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Cancer Res 2007, 67:3135-3144. 10.1158/0008-5472.CAN-06-3815, 17409420.
32. Guo W, Xu H, Chen J, Yang Y, Jin JW, Fu R, Liu HM, Zha XL, Zhang ZG, Huang WY. Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1. Mol Cell Biochem 2007, 295:167-177. 10.1007/s11010-006-9286-4, 17043753.
33. Verrecchia F, Rossert J, Mauviel A. Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J Invest Dermatol 2001, 116:755-763. 10.1046/j.1523-1747.2001.01326.x, 11348466.
34. Mack CL, Tucker RM, Sokol RJ, Kotzin BL. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005, 115:200-209. 10.1016/j.clim.2005.01.012, 1950158, 15885644.
35. Gibelli NE, Tannuri U, de Mello ES, Rodrigues CJ. Bile duct ligation in neonatal rats: Is it a valid experimental model for biliary atresia studies?. Pediatr Transplant 2008, 13:81-87. 10.1111/j.1399-3046.2008.00947.x, 18452497.